A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease Academic Article uri icon

Overview

MeSH Major

  • Computational Biology
  • Phenotype

abstract

  • ClinicalTrials.gov NCT01085045 . Registered 9 March 2010.

publication date

  • January 6, 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5216561

Digital Object Identifier (DOI)

  • 10.1186/s12931-016-0491-8

PubMed ID

  • 28061907

Additional Document Info

start page

  • 8

volume

  • 18

number

  • 1